HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].

AuthorsI A Sarkisova, V V Rameev, L V Kozlovskaia, N E Andreeva
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 75 Issue 8 Pg. 81-2 ( 2003) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitleUluchshenie prognoza generalizovannogo AL-amiloidoza u patsienta s mnozhestvennoĭ mielomoĭ pri lechenii po skheme VAD.
PMID14520860 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vincristine
  • Dexamethasone
  • Doxorubicin
Topics
  • Amyloidosis (complications, drug therapy)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Dexamethasone (administration & dosage, therapeutic use)
  • Doxorubicin (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma (complications, drug therapy)
  • Treatment Outcome
  • Vincristine (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: